Date | Price Target | Rating | Analyst |
---|---|---|---|
5/10/2024 | $11.00 | Overweight | Morgan Stanley |
2/28/2024 | $9.00 → $8.00 | Neutral → Sell | Goldman |
1/30/2024 | $11.00 → $9.00 | Neutral → Underweight | JP Morgan |
11/7/2023 | $9.00 | Neutral | UBS |
4/3/2023 | $11.00 | Neutral | Piper Sandler |
3/15/2023 | $12.00 | Neutral | JP Morgan |
1/4/2023 | $15.00 → $10.00 | Neutral → Underperform | BofA Securities |
1/3/2023 | $13.00 → $12.00 | Equal-Weight → Overweight | Morgan Stanley |
SC 13G/A - Enfusion, Inc. (0001868912) (Subject)
SC 13G/A - Enfusion, Inc. (0001868912) (Subject)
SC 13G/A - Enfusion, Inc. (0001868912) (Subject)
4 - Enfusion, Inc. (0001868912) (Issuer)
4 - Enfusion, Inc. (0001868912) (Issuer)
4 - Enfusion, Inc. (0001868912) (Issuer)
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 100 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $48.052 million which beat the analyst consensus estimate of $47.616 million by 0.92 percent. This is a 17.28 percent increase over sales of $40.971 million the same period last year.
https://www.sprucepointcap.com/research/enfusion-inc After conducting a forensic review of Enfusion, a technology provider for the investment management industry, Spruce Point believes that financial restatement risk is high and that the company is likely to disappoint investor expectations. Based on our investigation, we estimate a 40% to 60% downside risk.The report highlights several key concerns with the Company, including:Enfusion claims to be a high-growth SaaS provider of financial software with multi-year contracts, but we don't believe it to be a high quality oneThe company has experienced significant executive turnover including the CEO, CFO, Chief Revenue Officer (CRO), and Chief
Gainers Presto Automation (NASDAQ:PRST) shares rose 57.8% to $0.35 during Thursday's pre-market session. The company's market cap stands at $31.9 million. CCSC Technology (NASDAQ:CCTG) shares moved upwards by 31.04% to $4.39. The market value of their outstanding shares is at $50.8 million. Turtle Beach (NASDAQ:HEAR) shares increased by 30.09% to $14.35. The company's market cap stands at $249.7 million. The company's, Q4 earnings came out yesterday. Auddia (NASDAQ:AUUD) stock moved upwards by 22.18% to $3.36. The company's market cap stands at $2.7 million. BigBear.ai Hldgs (NYSE:BBAI) stock rose 19.91% to $2.95. The market value of their outstanding shares is at $647.3 million. Micro
Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00
Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously
JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its second quarter 2024 financial results as part of its Q2 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com. 2Q24 Earnings Conference Call Management will host a conference call today, August 6, 2024, at 8:30 AM ET to discuss the results. To pre-register for the live teleconference of the second quarter earnings call, please use this link. To access this call, dial (888) 596-4144. The conference ID number is 9652536. The earnings conference call will al
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2024 financial results before the U.S. financial markets open on Tuesday, August 6, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results. To access this call, dial (888) 596-4144. The conference ID number is 9652536. A live webcast of this conference call will be available on the Investor Relations page of Enfusion's website, http://ir.enfusion.com, and a replay will be archived on the website as well. About Enfusion Enfusion's investm
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its first quarter 2024 financial results as part of its 1Q 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com. 1Q24 Earnings Conference Call Management will host a conference call today, May 9, 2024, at 8:30 am ET to discuss the results. To pre-register for the live teleconference of the first quarter earnings call, please use this link. To access this call, dial (888) 596-4144. The conference ID number is 9652536. The earnings conference call will also be
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its second quarter 2024 financial results as part of its Q2 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com. 2Q24 Earnings Conference Call Management will host a conference call today, August 6, 2024, at 8:30 AM ET to discuss the results. To pre-register for the live teleconference of the second quarter earnings call, please use this link. To access this call, dial (888) 596-4144. The conference ID number is 9652536. The earnings conference call will al
New Portfolio Management Features Elevate Experiences for Asset Managers with Advanced Portfolio Construction, Rebalancing, and Integration with Third-party Optimizers Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the release of the next phase of Portfolio Workbench, bringing even more powerful portfolio rebalancing and construction features to users. Portfolio Workbench enables portfolio managers (PMs) to seamlessly manage and adjust their portfolios using a single intuitive user interface. The newest version adds support for rebalancing across multiple models, integration with portfolio op
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2024 financial results before the U.S. financial markets open on Tuesday, August 6, 2024. Management will host a conference call and webcast that same morning at 5:30 AM (PT) / 8:30 AM (ET) to discuss the results. To access this call, dial (888) 596-4144. The conference ID number is 9652536. A live webcast of this conference call will be available on the Investor Relations page of Enfusion's website, http://ir.enfusion.com, and a replay will be archived on the website as well. About Enfusion Enfusion's investm
10-Q - Enfusion, Inc. (0001868912) (Filer)
8-K - Enfusion, Inc. (0001868912) (Filer)
8-K - Enfusion, Inc. (0001868912) (Filer)
As part of the expansion, Richard Earnshaw joins as partner to lead new office and FTV's European investing efforts alongside growing team FTV Capital, a prominent sector-focused growth equity investment firm with a successful 25+-year track record of investing in financial and enterprise technology, today announced the opening of its London office to serve as the firm's hub for UK and European investments. FTV also announced Richard Earnshaw has joined the firm as partner to lead and grow the London-based team while deepening the firm's investing efforts throughout Europe. Located in Mayfair, FTV's London office joins the firm's existing offices in New York, San Francisco and Connecticut
Founder Bob Kaufman transitions to chairman of the board ConnexPay, the world's first all-in-one payments platform, today announced the appointment of Ben Peters as chief executive officer. Peters brings more than two decades of experience leading and scaling global payments and vertical software companies. Bob Kaufman, founder of ConnexPay, will remain actively involved in the business, assuming the role of chairman of the board of directors and working alongside Peters to continue driving ConnexPay's strong growth trajectory. "Under Bob's leadership, ConnexPay has built a unique end-to-end platform to both accept and make payments globally that is transforming payments experiences for
Forge Global Holdings, Inc. (NYSE:FRGE) ("Forge"), a global private securities marketplace, announced today the appointment of Larry Leibowitz to its Board of Directors, as well as its Compensation Committee. Mr. Leibowitz brings to Forge decades of entrepreneurial and corporate leadership experience in capital markets, financial technology and asset management. He is currently the CEO of Entrypoint Capital, a quantitative investment management firm, and has also held executive and board positions at a myriad of other companies in the financial services and investment sectors, including as the Chief Operating Officer, Head of Global Equities Markets, and Member of the Board of Directors o